UNC Lineberger Comprehensive Cancer Center

Kutatók

• IRImran Rizvi

Futó vizsgálatok

• Még nem toboroz

  Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

  NCT07078838· 2. fázis· UNC Lineberger Comprehensive Cancer Center· Forrás

• Még nem toboroz

  BLinatumomab and iNKT in Relapsed B-Cell ALL

  NCT07869368· 1. fázis· UNC Lineberger Comprehensive Cancer Center· Forrás

• Még nem toboroz

  Revumenib, Azacitidine, and VENetoclax in Newly Diagnosed KMT2A-Rearranged AML

  NCT07605949· 2. fázis· UNC Lineberger Comprehensive Cancer Center· Forrás

• Még nem toboroz

  A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma

  NCT07728188· 3. fázis· AbbVie· Forrás

• Toboroz

  Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes

  NCT07672769· 2. fázis· Faron Pharmaceuticals Ltd· Forrás

• Még nem toboroz

  Characterizing Tumor Hypoxia With BOLD-MRI to Predict Y-90 Treatment Response

  NCT07916376· UNC Lineberger Comprehensive Cancer Center· Forrás

• Még nem toboroz

  The PharmFIT Study

  NCT06656936· UNC Lineberger Comprehensive Cancer Center· Forrás

• Toboroz

  A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

  NCT07293247· 2. fázis· Alliance for Clinical Trials in Oncology· Forrás

• Toboroz

  Assessing Survival Outcomes With Checkpoint Inhibition ExteNded vs Discontinued in Endometrial Cancer

  NCT07867002· 3. fázis· UNC Lineberger Comprehensive Cancer Center· Forrás

• Még nem toboroz

  SURGIMEDIA: Utilization of Multimedia for Enhanced Surgical Consent

  NCT07494994· UNC Lineberger Comprehensive Cancer Center· Forrás

• Még nem toboroz

  Study on Treatment Outcome Patterns for Patients With CLL After Discontinuation of BTK Inhibitors

  NCT07526597· 2. fázis· UNC Lineberger Comprehensive Cancer Center· Forrás

• Toboroz

  Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease

  NCT07685938· 2. fázis· UNC Lineberger Comprehensive Cancer Center· Forrás

• Toboroz

  NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma

  NCT07740941· 2. fázis· UNC Lineberger Comprehensive Cancer Center· Forrás

• Toboroz

  Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMID Trial

  NCT07220187· 3. fázis· SWOG Cancer Research Network· Forrás

• Toboroz

  Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus

  NCT06732388· 2. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia

  NCT07061951· 2. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

  NCT07513376· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)

  NCT07634653· UNC Lineberger Comprehensive Cancer Center· Forrás

• Toboroz

  Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

  NCT07321652· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás

• Toboroz

  Tirzepatide in Obesity-Driven Endometrial Cancer

  NCT07065552· Korai 1. fázis· UNC Lineberger Comprehensive Cancer Center· Forrás

• Toboroz

  Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

  NCT07195734· 2. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease

  NCT07069595· 2. fázis· UNC Lineberger Comprehensive Cancer Center· Forrás

• Toboroz

  Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

  NCT07340541· 2. fázis· UNC Lineberger Comprehensive Cancer Center· Forrás

• Toboroz

  Hyaluronic Acid-based Gel Spacers in Gynecologic Malignancies

  NCT07292818· 1. fázis· UNC Lineberger Comprehensive Cancer Center· Forrás

• Toboroz

  Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

  NCT07198074· 3. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  Digoxin Medulloblastoma Study

  NCT06701812· 2. fázis· H. Lee Moffitt Cancer Center and Research Institute· Forrás

• Toboroz

  Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)

  NCT07281430· National Cancer Institute (NCI)· Forrás

• Toboroz

  Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

  NCT07061977· 3. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

  NCT07001748· 2/3. fázis· ECOG-ACRIN Cancer Research Group· Forrás

• Toboroz

  Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

  NCT07097142· 3. fázis· NRG Oncology· Forrás

• Toboroz

  Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

  NCT06958328· 3. fázis· NRG Oncology· Forrás

• Toboroz

  Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer

  NCT06727773· 2. fázis· UNC Lineberger Comprehensive Cancer Center· Forrás

• Toboroz

  A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers

  NCT06697600· University of Rochester· Forrás

• Toboroz

  PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

  NCT06896162· UNC Lineberger Comprehensive Cancer Center· Forrás

• Toboroz

  Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

  NCT06724237· 3. fázis· Eastern Cooperative Oncology Group· Forrás

• Toboroz

  The Vanguard Study: Testing a New Way to Screen for Cancer

  NCT06995898· National Cancer Institute (NCI)· Forrás

• Toboroz

  Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

  NCT06317662· 2. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

  NCT06770582· 2. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

  NCT06124157· 2. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  Designing Visual Tools to Enhance Cancer Surgeon Decision-making

  NCT06965192· UNC Lineberger Comprehensive Cancer Center· Forrás

• Toboroz

  A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

  NCT06401330· 3. fázis· Children's Oncology Group· Forrás

• Toboroz

  Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

  NCT06589804· 3. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

  NCT06647953· 3. fázis· Children's Oncology Group· Forrás

• Toboroz

  DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

  NCT06805305· 2. fázis· Diakonos Oncology Corporation· Forrás

• Toboroz

  Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

  NCT06661720· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás

• Toboroz

  Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  NCT06580314· 3. fázis· NRG Oncology· Forrás

• Toboroz

  Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

  NCT06513962· 3. fázis· Children's Oncology Group· Forrás

• Toboroz

  Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

  NCT06632977· 2. fázis· Alliance for Clinical Trials in Oncology· Forrás

• Toboroz

  Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel

  NCT06483555· 1/2. fázis· UNC Lineberger Comprehensive Cancer Center· Forrás

• Toboroz

  Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

  NCT06475989· 3. fázis· ECOG-ACRIN Cancer Research Group· Forrás

Showing 50 of 273.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Gyermekkori daganatok25 toboroz
• Akut limfoid leukémia (ALL)11 toboroz
• Akut mieloid leukémia (AML)9 toboroz
• Hasnyálmirigyrák9 toboroz
• Krónikus limfoid leukémia (CLL)9 toboroz
• Fej-nyaki daganatok8 toboroz
• Tüdőrák8 toboroz
• Hólyagrák7 toboroz
• Mielodiszplasztikus szindróma (MDS)7 toboroz
• Mielóma multiplex7 toboroz
• Petefészekrák7 toboroz
• Méhtestrák6 toboroz
• Follikuláris limfóma5 toboroz
• Gyomor- és nyelőcsőrák5 toboroz
• Tripla negatív emlőrák5 toboroz
• Vesedaganat5 toboroz
• Áttétes emlőrák4 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)4 toboroz
• Köpenysejtes limfóma4 toboroz
• Mieloproliferatív neopláziák4 toboroz
• Prosztatarák4 toboroz
• Szarkóma4 toboroz
• Vastagbélrák4 toboroz
• Amiloidózis3 toboroz
• Down syndrome3 toboroz
• Elhízás3 toboroz
• Hodgkin-limfóma3 toboroz
• Krónikus mieloid leukémia (CML)3 toboroz
• Méhnyakrák3 toboroz
• Neuroblasztóma3 toboroz
• Barrett's oesophagus2 toboroz
• Glioblasztóma2 toboroz
• Máj- és epeúti rák2 toboroz
• Melanóma2 toboroz
• Neuroendokrin daganatok2 toboroz
• Aplastic anaemia1 toboroz
• Hearing loss1 toboroz
• Pajzsmirigyrák1 toboroz

Lezárt vizsgálatok

• Visszavonták

  Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation

  NCT06348147· 2. fázis· UNC Lineberger Comprehensive Cancer Center· Forrás

• Leállították

  Digital Art Therapy for Young Cancer Survivors

  NCT06789666· UNC Lineberger Comprehensive Cancer Center· Forrás

• Visszavonták

  Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells

  NCT07071909· 1/2. fázis· UNC Lineberger Comprehensive Cancer Center· Forrás

• Leállították

  Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter

  NCT06359379· 2. fázis· Shuttle Pharmaceuticals, Inc.· Forrás

• Lezárult

  Little Cigar and Cigarillo Warnings for Youth

  NCT06413797· UNC Lineberger Comprehensive Cancer Center· Forrás

• Leállították

  Abequolixron (RGX-104) and Durvalumab in Lung Cancer

  NCT05911308· 1. fázis· UNC Lineberger Comprehensive Cancer Center· Forrás

• Lezárult

  Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer Survivors

  NCT06171945· UNC Lineberger Comprehensive Cancer Center· Forrás

• Lezárult

  Measuring Changes in Body Composition and Physical Function in Patients With Childhood Cancers

  NCT05823740· UNC Lineberger Comprehensive Cancer Center· Forrás

• Leállították

  Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma

  NCT05498220· 2. fázis· UNC Lineberger Comprehensive Cancer Center· Forrás

• Lezárult

  Physical Function During ARSI Treatment

  NCT05612880· UNC Lineberger Comprehensive Cancer Center· Forrás

• Leállították

  Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML

  NCT05275439· 1. fázis· Shattuck Labs, Inc.· Forrás

• Visszavonták

  Neoadjuvant Therapy for Localized Rectal Adenocarcinoma

  NCT04418895· 2. fázis· UNC Lineberger Comprehensive Cancer Center· Forrás

• Lezárult

  Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM

  NCT04471844· NovoCure Ltd.· Forrás

• Lezárult

  Binimetinib and Palbociclib or TAS-102 in Treating Patients With KRAS and NRAS Mutant Metastatic or Unresectable Colorectal Cancer

  NCT03981614· 2. fázis· Academic and Community Cancer Research United· Forrás

• Lezárult

  Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN

  NCT03529422· 2. fázis· UNC Lineberger Comprehensive Cancer Center· Forrás

• Lezárult

  High Intensity Interval Training in Endometrial Cancer

  NCT04025229· UNC Lineberger Comprehensive Cancer Center· Forrás

• Lezárult

  Evaluating Sexual Function in Women Undergoing a Radical Cystectomy for Bladder Cancer

  NCT05399004· Mayo Clinic· Forrás

• Lezárult

  GRADE-SRM: Genomic Risk Assessment and Decisional Evaluation for Small Renal Masses

  NCT03819569· UNC Lineberger Comprehensive Cancer Center· Forrás

• Lezárult

  BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma

  NCT03264131· 2. fázis· UNC Lineberger Comprehensive Cancer Center· Forrás

• Lezárult

  Testing the Effects of Palbociclib and Fulvestrant or Letrozole for Patients 70 Years of Age of Older With Metastatic Breast Cancer

  NCT03633331· 2. fázis· Alliance for Clinical Trials in Oncology· Forrás

• Lezárult

  Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML

  NCT03258931· 3. fázis· Arog Pharmaceuticals, Inc.· Forrás

• Lezárult

  Navtemadlin and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma

  NCT03217266· 1. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

  NCT03258554· 2/3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Palbociclib and Cetuximab in Metastatic Colorectal Cancer

  NCT03446157· 2. fázis· UNC Lineberger Comprehensive Cancer Center· Forrás

• Lezárult

  PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC

  NCT03442569· 2. fázis· UNC Lineberger Comprehensive Cancer Center· Forrás

• Lezárult

  Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer

  NCT03201458· 2. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

  NCT03394365· 3. fázis· Pierre Fabre Medicament· Forrás

• Lezárult

  Biospecimen Analysis in Determining Effects of Chemotherapy on Fertility in Osteosarcoma Survivors

  NCT03206450· Children's Oncology Group· Forrás

• Lezárult

  Testing Treatment With Ipilimumab and Nivolumab Compared to Treatment With Ipilimumab Alone in Advanced Melanoma

  NCT03033576· 2. fázis· National Cancer Institute (NCI)· Forrás

• Leállították

  A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer

  NCT03288545· 1/2. fázis· Astellas Pharma Global Development, Inc.· Forrás

• Leállították

  Afatinib in Advanced Refractory Urothelial Cancer

  NCT02122172· 2. fázis· University of Chicago· Forrás

• Lezárult

  Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer

  NCT03274687· 3. fázis· NRG Oncology· Forrás

• Lezárult

  Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

  NCT03080883· 3. fázis· Academic and Community Cancer Research United· Forrás

• Lezárult

  Testing the Safety and Efficacy of the Combination of the Antibody Pembrolizumab and Entinostat in Patients With Myelodysplastic Syndrome Who Are Not Responding to Hypomethylating Agents

  NCT02936752· 1. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

  NCT02975934· 3. fázis· pharmaand GmbH· Forrás

• Lezárult

  Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement

  NCT02828358· 2. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases

  NCT02595905· 2. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer

  NCT02520778· 1. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  High Dose Cytarabine Followed by Pembrolizumab in Relapsed/Refractory AML

  NCT02768792· 2. fázis· UNC Lineberger Comprehensive Cancer Center· Forrás

• Lezárult

  Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).

  NCT02831959· 3. fázis· NovoCure GmbH· Forrás

• Lezárult

  Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma

  NCT02807636· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  Pembrolizumab + Radiation for Locally Adv SCC of the Head and Neck (SCCHN) Not Eligible Cisplatin

  NCT02609503· 2. fázis· UNC Lineberger Comprehensive Cancer Center· Forrás

• Lezárult

  Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma

  NCT02470091· 2. fázis· Children's Oncology Group· Forrás

• Leállították

  Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

  NCT02408861· 1. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival

  NCT02364557· 2/3. fázis· NRG Oncology· Forrás

• Lezárult

  Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

  NCT02180867· 2/3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer

  NCT02101788· 2/3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients

  NCT02035787· 2. fázis· UNC Lineberger Comprehensive Cancer Center· Forrás

• Lezárult

  Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer

  NCT02003209· 3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma

  NCT01979536· 2. fázis· National Cancer Institute (NCI)· Forrás

Showing 50 of 85.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Tripla negatív emlőrák31 munka · 11 vizsgálat
• Hasnyálmirigyrák28 munka · 15 vizsgálat
• Hólyagrák27 munka · 21 vizsgálat
• Áttétes emlőrák23 munka · 17 vizsgálat
• Méhtestrák16 munka · 16 vizsgálat
• Mielodiszplasztikus szindróma (MDS)8 munka · 15 vizsgálat